Repeat corneal transplantation in Southern China: Indications, surgical technique, outcomes, and risk factors for repeat keratoplasty failure

医学 外科 角膜移植 移植 眼科
作者
Qi Zheng,Qinxiang Zheng,Wuhe Chen,Jinyang Li,Zelin Zhao,Haiou Wang,Dan Jiang,Wei Chen
出处
期刊:Indian Journal of Ophthalmology [Medknow]
卷期号:72 (Suppl 3): S482-S487
标识
DOI:10.4103/ijo.ijo_3333_23
摘要

Purpose: To report the indications, surgical techniques, and outcomes of repeat keratoplasty and evaluate the risk factors for graft failure in the Chinese population. Methods: The medical records of 216 patients (243 cases) who underwent at least two keratoplasties at a leading eye hospital in southern China between 2011 and 2020 were retrospectively reviewed. Indications and surgical procedures for repeat corneal transplantation were analyzed. Kaplan–Meier survival analysis was used to determine the graft survival rate after repeat keratoplasty. A multivariable survival model was used to assess the risk factors. Results: Repeated keratoplasties increased continuously from 2011 to 2020 ( P = 0.002). The most common primary indication was infectious keratitis (38.7%), and the most common reason for repeat keratoplasty was graft rejection (30.04%). Regraft techniques included penetrating keratoplasty (PK) in 165 cases (67.9%), deep lamellar keratoplasty (DALK) in 52 cases (21.40%), and endothelial keratoplasty (EK) in 26 cases (10.7%). Median survival was 5.3, 6.8, and 6.4 years for PK, DALK, and EK, respectively. The 5-year survival rate was 53.5%, 66.6%, and 69.8% for PK, DALK, and EK, respectively. The median LogMAR visual acuity was 1.4 for PK, 0.75 for DALK, and 1.2 for EK at the end of the follow-up. Multivariate analysis revealed that graft rejection is a risk factor for repeat keratoplasty failure ( P = 0.002). Conclusions: DALK and EK may provide better outcomes than PK in treating graft failure. Preventing and treating postoperative graft rejection may be key to improving regraft survival. These findings will aid in the management of failed corneal grafts.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ROY完成签到,获得积分10
刚刚
1秒前
小蘑菇应助科研通管家采纳,获得10
1秒前
李爱国应助科研通管家采纳,获得10
1秒前
1秒前
赘婿应助科研通管家采纳,获得10
1秒前
2秒前
赘婿应助科研通管家采纳,获得10
2秒前
风趣冷雁完成签到 ,获得积分10
2秒前
科目三应助科研通管家采纳,获得10
2秒前
科目三应助科研通管家采纳,获得10
2秒前
研友_LBr1lL应助科研通管家采纳,获得10
2秒前
今后应助科研通管家采纳,获得10
2秒前
Jasper应助科研通管家采纳,获得10
2秒前
2秒前
MP应助科研通管家采纳,获得30
2秒前
大模型应助科研通管家采纳,获得10
2秒前
科目三应助科研通管家采纳,获得10
2秒前
朴素的啤酒完成签到,获得积分10
2秒前
godblessyou应助科研通管家采纳,获得10
2秒前
2秒前
2秒前
2秒前
3秒前
3秒前
顾矜应助科研通管家采纳,获得10
3秒前
3秒前
3秒前
王木木应助科研通管家采纳,获得20
3秒前
科研通AI6.1应助李李采纳,获得10
3秒前
CodeCraft应助科研通管家采纳,获得10
3秒前
godblessyou应助科研通管家采纳,获得10
3秒前
3秒前
大个应助科研通管家采纳,获得10
3秒前
大模型应助科研通管家采纳,获得10
3秒前
烟花应助科研通管家采纳,获得10
3秒前
妤懿完成签到 ,获得积分10
4秒前
4秒前
5秒前
桃子发布了新的文献求助10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
卤化钙钛矿人工突触的研究 2000
Моделирование процессов самоорганизации в кристаллообразующих системах 1000
History of U.S. Space Surveillance and Satellite Cataloging 1000
Malcolm Fraser : a biography 700
Handbook of Optical Systems,Volume 6:Advanced Physical Optics 666
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6514827
求助须知:如何正确求助?哪些是违规求助? 8308202
关于积分的说明 17755052
捐赠科研通 5616624
什么是DOI,文献DOI怎么找? 2924768
邀请新用户注册赠送积分活动 1901797
关于科研通互助平台的介绍 1763125